BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

277 related articles for article (PubMed ID: 15363060)

  • 1. Sensory CIDP presenting as cryptogenic sensory polyneuropathy.
    Chin RL; Latov N; Sander HW; Hays AP; Croul SE; Magda P; Brannagan TH
    J Peripher Nerv Syst; 2004 Sep; 9(3):132-7. PubMed ID: 15363060
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Different electrophysiological profiles and treatment response in 'typical' and 'atypical' chronic inflammatory demyelinating polyneuropathy.
    Kuwabara S; Isose S; Mori M; Mitsuma S; Sawai S; Beppu M; Sekiguchi Y; Misawa S
    J Neurol Neurosurg Psychiatry; 2015 Oct; 86(10):1054-9. PubMed ID: 25424435
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The value of sensory electrophysiology in chronic inflammatory demyelinating polyneuropathy.
    Rajabally YA; Narasimhan M
    Clin Neurophysiol; 2007 Sep; 118(9):1999-2004. PubMed ID: 17644033
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Atypical electrophysiologic findings in chronic inflammatory demyelinating polyneuropathy (CIDP)--diagnosis confirmed by nerve biopsy.
    Boukhris S; Magy L; Kabore R; Mabrouk T; Li Y; Sindou P; Tabaraud F; Vallat JM
    Neurophysiol Clin; 2004 Apr; 34(2):71-9. PubMed ID: 15130553
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nerve excitability changes after intravenous immunoglobulin infusions in multifocal motor neuropathy and chronic inflammatory demyelinating neuropathy.
    Boërio D; Créange A; Hogrel JY; Guéguen A; Bertrand D; Lefaucheur JP
    J Neurol Sci; 2010 May; 292(1-2):63-71. PubMed ID: 20219211
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Chronic dysimmune neuropathy. A subclassification based upon the clinical features of 102 patients.
    Busby M; Donaghy M
    J Neurol; 2003 Jun; 250(6):714-24. PubMed ID: 12796835
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Electrophysiological sensory demyelination in typical chronic inflammatory demyelinating polyneuropathy.
    Rajabally YA; Samarasekera S
    Eur J Neurol; 2010 Jul; 17(7):939-44. PubMed ID: 20158514
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Patients who meet electrodiagnostic criteria for CIDP rarely present with a sensory predominant DSP phenotype.
    Davalos L; London ZN; Stino AM; Gallagher GW; Callaghan BC; Wieland CM; Nowacek DG
    Muscle Nerve; 2021 Jun; 63(6):881-884. PubMed ID: 33745140
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Macrophage clustering as a diagnostic marker in sural nerve biopsies of patients with CIDP.
    Sommer C; Koch S; Lammens M; Gabreels-Festen A; Stoll G; Toyka KV
    Neurology; 2005 Dec; 65(12):1924-9. PubMed ID: 16380614
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Diagnostic value of sural nerve demyelination in chronic inflammatory demyelinating polyneuropathy.
    Bosboom WM; van den Berg LH; Franssen H; Giesbergen PC; Flach HZ; van Putten AM; Veldman H; Wokke JH
    Brain; 2001 Dec; 124(Pt 12):2427-38. PubMed ID: 11701597
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Uniform demyelination and more severe axonal loss distinguish POEMS syndrome from CIDP.
    Mauermann ML; Sorenson EJ; Dispenzieri A; Mandrekar J; Suarez GA; Dyck PJ; Dyck PJ
    J Neurol Neurosurg Psychiatry; 2012 May; 83(5):480-6. PubMed ID: 22396441
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Research criteria for defining patients with CIDP.
    Sander HW; Latov N
    Neurology; 2003 Apr; 60(8 Suppl 3):S8-15. PubMed ID: 12707417
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Intravenous immunoglobulin is effective in patients with diabetes and with chronic inflammatory demyelinating polyneuropathy: long term follow-up.
    Jann S; Bramerio MA; Facchetti D; Sterzi R
    J Neurol Neurosurg Psychiatry; 2009 Jan; 80(1):70-3. PubMed ID: 18768571
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The diagnostic value of sural nerve T cells in chronic inflammatory demyelinating polyneuropathy.
    Bosboom WM; Van den Berg LH; De Boer L; Van Son MJ; Veldman H; Franssen H; Logtenberg T; Wokke JH
    Neurology; 1999 Sep; 53(4):837-45. PubMed ID: 10489051
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of patients with refractory chronic inflammatory demyelinating polyneuropathy.
    Kaplan A; Brannagan TH
    Muscle Nerve; 2017 Apr; 55(4):476-482. PubMed ID: 27463215
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Amyloid neuropathy mimicking chronic inflammatory demyelinating polyneuropathy.
    Mathis S; Magy L; Diallo L; Boukhris S; Vallat JM
    Muscle Nerve; 2012 Jan; 45(1):26-31. PubMed ID: 22190302
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Chronic inflammatory demyelinating polyneuropathy (CIDP) in diabetics.
    Stewart JD; McKelvey R; Durcan L; Carpenter S; Karpati G
    J Neurol Sci; 1996 Oct; 142(1-2):59-64. PubMed ID: 8902721
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pain as the presenting symptom of chronic inflammatory demyelinating polyradiculoneuropathy (CIDP).
    Boukhris S; Magy L; Khalil M; Sindou P; Vallat JM
    J Neurol Sci; 2007 Mar; 254(1-2):33-8. PubMed ID: 17286985
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Chronic inflammatory axonal polyneuropathy.
    Oh SJ; Lu L; Alsharabati M; Morgan MB; King P
    J Neurol Neurosurg Psychiatry; 2020 Nov; 91(11):1175-1180. PubMed ID: 32917820
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ataxic form of chronic inflammatory demyelinating polyradiculoneuropathy: clinical features and pathological study of the sural nerves.
    Ohkoshi N; Harada K; Nagata H; Yato M; Shoji S
    Eur Neurol; 2001; 45(4):241-8. PubMed ID: 11385262
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.